rs75099879

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_006996.3(SLC19A2):​c.796G>A​(p.Val266Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,613,658 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0069 ( 12 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 8 hom. )

Consequence

SLC19A2
NM_006996.3 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -2.48

Publications

5 publications found
Variant links:
Genes affected
SLC19A2 (HGNC:10938): (solute carrier family 19 member 2) This gene encodes the thiamin transporter protein. Mutations in this gene cause thiamin-responsive megaloblastic anemia syndrome (TRMA), which is an autosomal recessive disorder characterized by diabetes mellitus, megaloblastic anemia and sensorineural deafness. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]
SLC19A2 Gene-Disease associations (from GenCC):
  • thiamine-responsive megaloblastic anemia syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035036802).
BP6
Variant 1-169477166-C-T is Benign according to our data. Variant chr1-169477166-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 293525.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00692 (1054/152288) while in subpopulation AFR AF = 0.024 (996/41538). AF 95% confidence interval is 0.0227. There are 12 homozygotes in GnomAd4. There are 532 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006996.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC19A2
NM_006996.3
MANE Select
c.796G>Ap.Val266Met
missense
Exon 2 of 6NP_008927.1O60779-1
SLC19A2
NM_001319667.1
c.205-6980G>A
intron
N/ANP_001306596.1A0A024R8Y5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC19A2
ENST00000236137.10
TSL:1 MANE Select
c.796G>Ap.Val266Met
missense
Exon 2 of 6ENSP00000236137.5O60779-1
SLC19A2
ENST00000367804.4
TSL:1
c.205-6980G>A
intron
N/AENSP00000356778.3O60779-2
SLC19A2
ENST00000646596.1
c.796G>Ap.Val266Met
missense
Exon 2 of 6ENSP00000494404.1A0A2R8Y5B5

Frequencies

GnomAD3 genomes
AF:
0.00689
AC:
1049
AN:
152170
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0239
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00222
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00190
AC:
477
AN:
250962
AF XY:
0.00164
show subpopulations
Gnomad AFR exome
AF:
0.0250
Gnomad AMR exome
AF:
0.00142
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000176
Gnomad OTH exome
AF:
0.000817
GnomAD4 exome
AF:
0.000687
AC:
1004
AN:
1461370
Hom.:
8
Cov.:
34
AF XY:
0.000607
AC XY:
441
AN XY:
727016
show subpopulations
African (AFR)
AF:
0.0212
AC:
711
AN:
33460
American (AMR)
AF:
0.00152
AC:
68
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86224
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00164
AC:
9
AN:
5484
European-Non Finnish (NFE)
AF:
0.000115
AC:
128
AN:
1111882
Other (OTH)
AF:
0.00136
AC:
82
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00692
AC:
1054
AN:
152288
Hom.:
12
Cov.:
32
AF XY:
0.00714
AC XY:
532
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0240
AC:
996
AN:
41538
American (AMR)
AF:
0.00222
AC:
34
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68030
Other (OTH)
AF:
0.00427
AC:
9
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
47
95
142
190
237
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00289
Hom.:
9
Bravo
AF:
0.00796
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.0247
AC:
109
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.00231
AC:
281
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness (1)
-
-
1
Monogenic diabetes (1)
-
-
1
not provided (1)
-
1
-
Thiamine-responsive megaloblastic anemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
0.0020
DANN
Benign
0.83
DEOGEN2
Benign
0.25
T
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.30
T
MetaRNN
Benign
0.0035
T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
0.49
N
PhyloP100
-2.5
PrimateAI
Benign
0.22
T
PROVEAN
Benign
0.0
N
REVEL
Benign
0.26
Sift
Benign
0.14
T
Sift4G
Benign
0.14
T
Polyphen
0.0020
B
Vest4
0.13
MVP
0.32
MPC
0.17
ClinPred
0.0065
T
GERP RS
-11
Varity_R
0.021
gMVP
0.15
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75099879; hg19: chr1-169446404; API